Palm: Analysts' Upgrades, Downgrades - TheStreet

Palm: Analysts' Upgrades, Downgrades

Palm downgraded at UBS, Kaufman and estimates, target lowered at Citigroup.
Author:
Publish date:

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Amylin Pharmaceuticals

(AMLN)

initiated at Credit Suisse with an Outperform rating and $28 price target. Improved confidence in next generation, once-weekly Byetta should generate upside.

AthenaHealth

(ATHN) - Get Report

downgraded at JMP from Outperform to Market Perform. Accounting issues could have a ripple effect on customers.

AthenaHealth

(ATHN) - Get Report

downgraded at Baird from Outperform to Neutral. Company delayed results for an accounting review. New $35 price target.

Fluor

(FLR) - Get Report

downgraded at Baird from Outperform to Neutral. Company cut earnings guidance. New $47 price target.

Lamar Advertising

(LAMR) - Get Report

upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $36 from $33. 2010 EPS estimates lowered to -$0.53 from -$0.46.

Motorola

(MOT)

downgraded at UBS from Buy to Neutral. Valuation call, based on a $7.50 price target.

Ormat Technologies

(ORA) - Get Report

downgraded at Piper Jaffray. Rating lowered to Neutral from Overweight. Price target lowered to $30 from $43. 2010 EPS estimates lowered to $0.75 from $1.54.

Palm

(PALM)

downgraded at UBS from Neutral to Sell. $4.50 price target. Weak launch at Verizon, will likely cause the company to become more competitive with pricing.

Palm

(PALM)

estimates, target lowered at Citigroup Shares of PALM now seen reaching $7.75. Estimates also cut, to match the company's new guidance. A capital raise will also likely be necessary. Hold rating.

Palm

(PALM)

downgraded at Kaufman from Buy to Hold. Company may not reach profitability for another 4-6 quarters. New $7.50 price target.

STOCK COMMENTS / EPS CHANGES

Blackstone

(BX) - Get Report

estimates increased at Morgan Stanley through 2011. Company is positioned well for weaker capital markets. Overweight rating and $18 price target.

Cinemark

(CNK) - Get Report

target, estimate raised at Barclays. CNK price target jumped to $17 from $13 after stronger than expected 4Q09 results. 2010 EPS estimate lifted to 86 cents from 80 cents. Maintain Equal Weight rating.

Cablevision

(CVC)

price target boosted at BofA/Merrill. CVC price target raised to $29 on continued growth prospects. Maintain Buy rating.

El Paso

(EP)

target raised at UBS. Shares of EP now seen reaching $18. Company is seeing higher pipeline earnings. Buy rating.

Express Scripts

(ESRX)

numbers boosted at Morgan Stanley. Shares of ESRX now seen reaching $115. Estimates also raised, aided by the NetRx acquisition. Overweight rating.

Foster Wheeler

(FWLT)

target, estimate cut at Barclays. FWLT price target slashed to $38 from $42 after mixed 4Q09 results. 2010 EPS estimates lowered to $2.30 from $2.55. Maintain Overweight rating.

Gap

(GPS) - Get Report

estimates boosted at UBS through 2012. Company guided higher and should be able to grow its gross margin. Neutral rating and $21 price target.

Granite Construction

(GVA) - Get Report

numbers lowered at FBR. Shares of GVA now seen reaching $34. Estimates also cut, as increased competition is hurting margins. Outperform rating.

HJ Heinz

(HNZ)

estimates, target raised at Morgan Stanley. Shares of HNZ now seen reaching $51. Estimates also increased, as the company is realizing a higher gross margin. Overweight rating.

Holly

(HOC)

estimates reduced at Morgan Stanley. HOC estimates were lowered through 2011. Company is seeing smaller refining margins. Equal-weight rating and $30 price target.

Magna International

(MGA) - Get Report

estimates reduced at Citigroup through 2012. Company is being hurt by currency rates. Buy rating and $71 price target.

Mylan

(MYL) - Get Report

estimates, target increased at UBS. Shares of MYL now seen reaching $24. Estimates also raised, to match the company's new guidance. Buy rating.

Northrop Grumman

(NOC) - Get Report

estimates increased at Citigroup. NOC estimates were raised through 2011. Company boosted its guidance. Hold rating and new $62 price target.

Omnicare

(OCR)

estimates, target upped at UBS. Shares of OCR now seen reaching $28. Estimates also raised, because of share repurchases. Neutral rating.

Office Depot

(ODP) - Get Report

estimates raised at Morgan Stanley through 2011. Restructuring efforts should help earnings. Equal-weight rating.

Radio Shack

(RSH)

numbers upped at Morgan Stanley. RSH target was boosted to $24. Estimates also raised, because of wireless sales growth. Overweight rating.

Southwestern Energy

(SWN) - Get Report

estimates upped at UBS. SWN estimates were increased through 2011. Company is seeing higher production rates. Buy rating and $62 price target.

Safeway

(SWY)

estimates, target increased at UBS. Shares of SWY now seen reaching $25. Estimates also raised, as sales trends appear to be improving. Neutral rating.

Wendy's/Arby's

(WEN) - Get Report

estimates lowered at UBS. WEN estimates were cut through 2010. Softer sales at Arby's will continue to be a drag. Neutral rating and $4.75 price target.

This article was written by a staff member of TheStreet.com.